Study Of Flow Mediated Dilatation of Brachial Artery in Patients with Coronary Artery Disease in Relation to Diabetes Mellitus.
Background and Objectives: Coronary artery disease (CAD) results from interaction of many risk factors, environmental influence and genetic predisposition. Endothelial and vascular smooth muscle dysfunctions are early abnormalities in atherosclerosis development in cardiometabolic disease. Diabetes is a significant risk factor for cardiovascular disease due to elevated oxidant levels contributing to vascular dysfunction and impaired vasodilatory effect mediated through release of nitric oxide (NO). Endothelial function assessed by brachial artery Flow mediated dilatation (FMD), a non-invasive test has been shown to be impaired in patients of CAD. As diabetes has been CAD risk equivalent, this study is being done to evaluate the mean FMD value in patients with and without diabetes mellitus and to correlate endothelial dysfunction in these patients through FMD. Methods: A cross-sectional study was done from January 2020 to June 2021, in which 84 patients of CAD were enrolled after informed consent. The patients were divided into 2 groups of diabetics and non-diabetics. Statistical analysis was done to compare mean FMD value between the 2 groups of diabetes and non-diabetes patients by using independent sample t test and correlation of endothelial dysfunction in diabetes through FMD was done by chi square analysis. Results: The mean age of patient was 53.81±9.52 years, males were predominant than females in the study with sex ratio of 1:4. The mean duration of diabetes was 4.91 with SD 1.22 years. The mean FMD in SVD (Single vessel disease) was 9.43± 4.48%, in DVD (Double vessel disease) mean was 8.55±2.83% and in TVD (Triple vessel disease) was 5.707±1.93%. Among the various biochemical parameters, increased creatinine, FBS, PPBS and TG was found to be statistically significant with respect to diabetes (p<0.01). The mean FMD (%) was found to be lower with values of 5.87 ±2.03% ( p<0.001) in diabetic group than in non-diabetic group, whose mean FMD was 11.51±3.27%. Conclusion: The mean FMD was found to be lower in diabetic group than in non-diabetic group, suggesting increased endothelial dysfunction in diabetic patients compared to non-diabetics in patients with known CAD. Also, FMD was found to be negative correlated with risk of cardiovascular disease in diabetic patients, where lower FMD was found to be associated with higher risk of endothelial dysfunction. Therefore, FMD is a non-invasive, simple, reliable technique which serves as an alternative to invasive procedures and can help to identify patients with endothelial dysfunction who are at a higher risk of CAD, and initiate early and appropriate management.